Whether the given data are consistent with the fact that taurine exerts negative feedback on the release of vasopressin from the pituitary gland of the rat, and the reason behind the answer. The taurine released from pituitary gland over an hour, in the presence of vasopressin, is recorded in the following graph: Introduction: The pituitary gland is a part of the endocrine system that releases regulatory hormones. The two parts of pituitary gland secrete different types of hormones, for example, the growth hormone, prolactin, corticotrophin, and others. The anterior part of the pituitary gland releases vasopressin and the oxytocin hormones, which are almost similar in length to amino acids.

Question

Want to see the full answer?

Answer 1

Question

Chapter 38, Problem 1ITD

Summary Introduction

To review:

Whether the given data are consistent with the fact that taurine exerts negative feedback on the release of vasopressin from the pituitary gland of the rat, and the reason behind the answer. The taurine released from pituitary gland over an hour, in the presence of vasopressin, is recorded in the following graph:

Introduction:

The pituitary gland is a part of the endocrine system that releases regulatory hormones. The two parts of pituitary gland secrete different types of hormones, for example, the growth hormone, prolactin, corticotrophin, and others. The anterior part of the pituitary gland releases vasopressin and the oxytocin hormones, which are almost similar in length to amino acids.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

Outline a method for using apomixis to maintain feminized CannabisAssume apomixis is controlled by a single dominant gene. You can choose the type of apomixis: obligate or facultative, gametophytic or sporophytic. Discuss advantages and disadvantages of your proposed method.

Kinetics: One-Compartment First-Order Absorption 1. In vivo testing provides valuable insight into a drug’s kinetics. Assessing drug kinetics following multiple routes of administration provides greater insight than a single route of administration alone. The following data was collected in 250-g rats following bolus IV, oral (PO), and intraperitoneal (ip) administration. Using this data and set of graphs, determine:(calculate for each variable) (a) k, C0, V, and AUC* for the bolus iv data (b) k, ka, B1, and AUC* for the po data c) k, ka, B1, and AUC* for the ip data (d) relative bioavailability for po vs ip, Fpo/Fip (e)absolute ip bioavailability, Fip (f) absolute po bioavailability, Fpo

3. A promising new drug is being evaluated in human trials. Based on preliminary human tests, this drug is most effective when plasma levels exceed 30 mg/L. Measurements from preliminary tests indicate the following human pharmacokinetic parameter values: t1/2,elim = 4.6hr, t1/2,abs = 0.34hr, VD = 0.29 L/kg, Foral = 72%. Based on these parameters, estimate the following if a 49 kg woman were to receive a 1000mg oral dose of this drug: (a) Estimate the plasma concentration of the drug at 1hr, 6 hr, and 20hr after taking the drug ( Concentration estimate) (b) Estimate the time for maximum plasma concentration (tmax). (c) Estimate the maximum plasma concentration (Cmax). (d) Estimate the time at which the plasma level first rises above 30 mg/L. (Note this is a trial and error problem where you must guess a time, plug it into the concentration equation, and determine if it is close to 30 mg/L. Hint: based on part (a) it should be apparent that the answer is less than 1hr.) (e)…